Who We Are


Committed to Oncology


Because, every moment of life is precious for cancer patients



We at Beta Drugs Ltd, Strive for Affordability Accessibility Acceptability of medicines

Our Founder







"From the beginning, he realized that if medicine had to serve their purpose, they first had to be affordable & accessible".

Late Shri. Vijay Batra (1954-2021)

The Journey of Beta Drugs Limited (Adley Group) began in early 80's with the ardent efforts of Late Shri Vijay Batra. He was a visionary and businessman par excellence. He had foreseen the scope in niche segment like Oncology and laid the foundation of Indian Pharma Multinational in Oncology segment.

As guided by him, company is focusing on new product development. Comapany is set to launch 25 new products by year 2026 that includes NIB's, NDDS & PARP Inhibitors. His guiding force behind all the corporate decisions lead Beta Drugs Limited to achieve new heights over the years & became one of the most respected Oncology company in India.



Our Vision

To achieve a sustainable leadership in complex chemical synthesis for Anti-Cancer bulk drugs and finishes dosages.

Our Mission

To touch the lives of millions of cancer patients by expanding access to Quality & affordable drugs through cutting edge technology and advance R&D.


Our Promises

Our Values

Cost Effectiveness

We believe healthcare is only effective when it’s affordable, hence we put in extra efforts in ensuring that we make cost effective products by achieving economy of scale and backward integration.

Collaboration & Partnerships

We firmly believe, Success is best when it’s shared and hence we consider everyone who associates with us i.e. patients, industry partners, and the communities associated with us, as partners.

Care

We care about the well-being of our patients, care givers, and the communities we touch. We care about our colleagues, creating a respectful, inclusive and a diverse working environment.

Patient First

We understand patients, and how fighting a disease takes a toll on them, so every step we take is in the direction to try and make this fight easier, by focusing on driving better treatment outcomes and not compromising on quality & affordability.

Value through innovation

We constantly innovate to create better value for our patients, our partners in the healthcare system and our stakeholders. We persistently focus on originality and try to find better ways to excel by creating products for current and future unmet needs.

Focus & Accountability

We believe that as leaders we set the right example by focusing diligently on everything we do by defining clear objectives, efforts and attention to deliver. We always hold ourselves accountable to the promises we make through our products & research.

Leading the Way

We are passionate about being first to market and realizing opportunities, but we also ensure that we lead by example as leadership happens through and with the people.

Our Core Team

Rahul Batra

Chairman & Managing Director

Varun Batra

Joint Managing Director

Balwant Singh

Director

Ashutosh Shukla

V.P. Sales & Marketing

Dr. Sandeep Gupta

R & D Head

Dr. Sanjeev Chopra

V.P. Technical

Nipun Arora

CFO

Rajni Brar

CS

Our Milestones

1993

Laid the foundation of Adley Group by Late Shri. Vijay Batra

2007

Entered into Oncology Market

2008

Setup the first Oncology Unit in Adley Formulations Pvt Ltd.

2011

Foray into the international market

2014

Setup a new "state of the art" manufacturing facility for oncology formulations.

2015

Developed in-house Albumin bound Paclitaxel.

2017

Received SME Excellence Award

Listed in NSE - National Stock Exchange

Commenced In-house API Plant - Adley Labs

2018

Setup an oncology plant in Uzbekistan.

2020

Setup Inhouse PFS Facility

Launched GEM-RTU, ADLEAP, ADLANTE, BEXINIB

Launched 1st Indian Brand of Dasatinib, BEEDAN

2021

Launched 1st Indian brand of Sunitinib, ADSUNIB.